- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03375918
COmmuNity-engaged SimULation Training for Blood Pressure Control (CONSULT-BP)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
CONSULT-BP will adapt and test a theory-based, 'awareness, exposure and skill-building' intervention, applied in the safety of a simulation-based learning center, to improve providers' interaction skills with minority and poor patients. We will use our established platform of community-based participatory research to implement CONSULT-BP in an academic medical center with a large, safety-net health system that serves a minority and poor population. The CONSULT-BP project will: 1. recruit and hire Community Advisors (CA) representing diverse underserved populations who will participate in the adaptation of evidence-based hypertension communication tools and the design, development, and implementation of the training curriculum; 2. use online self-assessments of clinicians' implicit bias for race and patient compliance to raise bias self-awareness and to examine the effect of bias on knowledge and skill development; and 3. hire Community SPs to (a) conduct face-to-face, simulated clinical encounters with medical trainees and NP students, and (b) provide evaluation and feedback about communication skills along with trained CA observers and faculty facilitators. The educational intervention is a program of two, 180-minute, sessions, spaced 5 weeks apart that combine online learning with in-person skill practice.
To understand how much training exposure is required to 'move the needle' of clinical skills and patient outcomes, we will assess the effect of CONSULT-BP by conducting two, sequential, randomized trials. Trial 1 will evaluate the effectiveness of one-time CONSULT training on outcomes, and Trial 2 will evaluate the effect of repeat, booster training on outcomes. To support training feasibility in Trial 1, CONSULT-BP will train cohorts of IM, FM, and NP trainees over a 3-year period, and will target advanced (2nd or 3rd-year) trainees within a given academic year for one-time exposure to the training intervention. Within each academic year, we will randomize training times to 1 of 5 start dates using a stepped wedge design to accommodate pre-existing training schedules and to mitigate the effect of temporal trends in clinical skill proficiency. Trial 2 will randomly assign continuing trainee participants from Trial 1 to a second CONSULT-BP booster training exposure versus no booster training. The primary outcome for both trials will be patient BP control. Secondary process outcomes will include trainees' communication skills and patient adherence to medications, visits, and diet changes. We will also examine effect modification by patient characteristics (baseline BP control) and trainee characteristics (implicit bias and awareness of bias). Trainee measures will be from trainee self-report (implicit bias, bias awareness), community SP report (trainee communication skills), and clinic patient surveys (trainee communication quality and patient adherence). Clinical BP outcomes will be from the EMR. We will use analytic mixed effect models accounting for patient and clinician characteristics, patient correlations within randomization clusters and within clinicians, and repeated measures within patient. The CONSULT-BP multi-staged, community-engaged, education model will change how medical educators think about helping providers develop bias-aware, patient-centered, communication skills.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jennifer Tjia, MD, MSCE
- Phone Number: 774-455-3538
- Email: jennifer.tjia@umassmed.edu
Study Locations
-
-
Massachusetts
-
Barre, Massachusetts, United States, 01005
- Barre Family Health Center
-
Uxbridge, Massachusetts, United States, 01569
- Tri River Family Health Center
-
Worcester, Massachusetts, United States, 01605
- Edward M Kennedy Community Health Center
-
Worcester, Massachusetts, United States, 01605
- UMass Memorial Hahnemann Family Health Center
-
Worcester, Massachusetts, United States, 01605
- UMass Memorial Medical Center -- Benedict Building
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
For Healthcare Trainees -
Inclusion Criteria:
- Practice at a clinical site supported by an EMR to allow clinical data collection for outcome measurement
- 15-week clinical look-back period
- No prior completion of the CONSULT-BP intervention
Exclusion Criteria: 1. All 1st year trainees
For Patient Participants -
Inclusion Criteria:
- English-speaking
- Non-White racial/ethnic minority or Medicaid recipient (regardless of race/ethnicity)
- Hypertension identified in the EMR
Exclusion Criteria:
- Enrolled in hospice.
- Pregnancy, dementia, schizophrenia, bipolar illness, or other serious medical co-morbidity that would interfere with hypertension self-control
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Healthcare Trainees - Cluster 1
Within each academic year, trainee clusters are randomized to 1 of 5 start date training times for Other: CONSULT-BP Educational Intervention.
Each arm has a pre-intervention (control) period and a post-intervention (exposure) period.
|
The CONSULT-BP intervention includes two, 180-minute, in-persons sessions 5 weeks apart.
Each session has 3 parts: 1. Pre-"Clinical Practice Simulation" Learning; 2. Trainee Self-Assessments of implicit bias; and 3. In-Person "Clinical Practice Simulations" to practice communication skills, trigger reflection, and frame group-based reflections on bias.
|
Other: Healthcare Trainees - Cluster 2
Within each academic year, trainee clusters are randomized to 1 of 5 start date training times for Other: CONSULT-BP Educational Intervention.
Each arm has a pre-intervention (control) period and a post-intervention (exposure) period.
|
The CONSULT-BP intervention includes two, 180-minute, in-persons sessions 5 weeks apart.
Each session has 3 parts: 1. Pre-"Clinical Practice Simulation" Learning; 2. Trainee Self-Assessments of implicit bias; and 3. In-Person "Clinical Practice Simulations" to practice communication skills, trigger reflection, and frame group-based reflections on bias.
|
Other: Healthcare Trainees - Cluster 3
Within each academic year, trainee clusters are randomized to 1 of 5 start date training times for Other: CONSULT-BP Educational Intervention.
Each arm has a pre-intervention (control) period and a post-intervention (exposure) period.
|
The CONSULT-BP intervention includes two, 180-minute, in-persons sessions 5 weeks apart.
Each session has 3 parts: 1. Pre-"Clinical Practice Simulation" Learning; 2. Trainee Self-Assessments of implicit bias; and 3. In-Person "Clinical Practice Simulations" to practice communication skills, trigger reflection, and frame group-based reflections on bias.
|
Other: Healthcare Trainees - Cluster 4
Within each academic year, trainee clusters are randomized to 1 of 5 start date training times for Other: CONSULT-BP Educational Intervention.
Each arm has a pre-intervention (control) period and a post-intervention (exposure) period.
|
The CONSULT-BP intervention includes two, 180-minute, in-persons sessions 5 weeks apart.
Each session has 3 parts: 1. Pre-"Clinical Practice Simulation" Learning; 2. Trainee Self-Assessments of implicit bias; and 3. In-Person "Clinical Practice Simulations" to practice communication skills, trigger reflection, and frame group-based reflections on bias.
|
Other: Healthcare Trainees - Cluster 5
Within each academic year, trainee clusters are randomized to 1 of 5 start date training times for Other: CONSULT-BP Educational Intervention.
Each arm has a pre-intervention (control) period and a post-intervention (exposure) period.
|
The CONSULT-BP intervention includes two, 180-minute, in-persons sessions 5 weeks apart.
Each session has 3 parts: 1. Pre-"Clinical Practice Simulation" Learning; 2. Trainee Self-Assessments of implicit bias; and 3. In-Person "Clinical Practice Simulations" to practice communication skills, trigger reflection, and frame group-based reflections on bias.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood pressure
Time Frame: up to 6 months after the intervention
|
Systolic and diastolic blood pressure reported in the EMR
|
up to 6 months after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of Communication
Time Frame: up to 3 months after the intervention
|
Health Care Climate Questionnaire Six-item scale assesses beliefs regarding perceived provider support for autonomy and provider communicated care. Each item is evaluated on 7-point Likert scale (1 - 5 strongly agree, neutral, strongly disagree). Scores are calculated by averaging individual item scores. (Williams 1998 (a); Williams 1998(b)) Reference. Williams GC, Rodin GC, Ryan RM, Grolnick WS, Deci EL. Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychol. 1998;17(3):269-276. doi:10.1037/0278-6133.17.3.269. Williams GC, Freedman ZR, Deci EL. Supporting autonomy to motivate patients with diabetes for glucose control. Diabetes Care. 1998;21(10):1644-1651. doi:10.2337/diacare.21.10.1644 |
up to 3 months after the intervention
|
Patient Reported Trust in Heathcare Provider
Time Frame: up to 3 months after the intervention
|
The Primary Care Assessment Survey - Trust sub-scale Eight-item subscale of the the Primary Care Assessment measuring patient trust in their healthcare provider; each item is rated on a 5-point Likert Scale and transformed to a 100 point scale with higher scores indicating greater trust. The reported mean score is 75.68 (SD 16.04). Reference. Safran DG, Kosinski M, Tarlov AR, et al. The Primary Care Assessment Survey: tests of data quality and measurement performance. Med Care. 1998;36(5):728-739. |
up to 3 months after the intervention
|
Voils Medication Adherence Scale
Time Frame: up to 3 months after the intervention
|
Twenty-four item scale assess extent and reasons for non-adherence to medication. Each item is rated on a 5-point Likert scale. Summary scores are calculated separately for reason and extent of adherence. Reference: Voils CI, Maciejewski ML, Hoyle RH, Reeve BB, Gallagher P, Bryson CL, Yancy WS Jr. Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Med Care. 2012;50(12):1013-9. |
up to 3 months after the intervention
|
Blood Pressure Self Care Scale
Time Frame: up to 3 months after the intervention
|
Ten-item scale assesses knowledge and self-care practices on a 7-point Likert scale. Total scores are determined as the average of the scores on each item. Reference: Peters, R. M., & Templin, T. N. Measuring blood pressure knowledge and self-care behaviors of African Americans. Research in Nursing & Health, 2008; 31(6), 543-552. |
up to 3 months after the intervention
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jennifer Tjia, MD, MSCE, UMass Medical School
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H00012160
- 1R01MD011532 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on CONSULT-BP Educational Intervention
-
Cedars-Sinai Medical CenterNational Heart, Lung, and Blood Institute (NHLBI); University of California... and other collaboratorsCompleted
-
NYU Langone HealthThe Rainer Arnhold FoundationCompletedCoronary Artery Disease | Hypertension | Obesity | Diabetes | Peripheral Arterial Disease | Hyperlipidemia | PrediabetesUnited States
-
Icahn School of Medicine at Mount SinaiAT&T and Vital TechSuspended
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Active, not recruitingBreast CarcinomaUnited States
-
Duke UniversityBoehringer IngelheimRecruitingHeart Failure | Chronic Kidney Diseases | Type 2 DiabetesUnited States
-
University of Southern CaliforniaUniversity of California, Los Angeles; University of California, IrvineRecruitingMyocardial Infarction | Stroke | HypertensionUnited States
-
Brigham and Women's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruitingHypertension | Blood PressureUnited States
-
US Department of Veterans AffairsCompleted
-
Parthasarathy ThirumalaCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBacterial Infection | Clostridium DifficileUnited States